Feb 13 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2022 Dec 31, 2021 Dec 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 448 mln 414 mln 400 mln
(+8.1 pct) (+16.5 pct) (-10.7 pct)
Operating loss 305 mln loss 171 mln loss 1.40
Recurring loss 295 mln loss 159 mln loss 1.41
Net
Net loss 429 mln loss 148 mln loss 1.39
EPS loss 14.50 yen loss 5.08 yen loss 44.60 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T